Not exact matches
Two powerhouses in the
life sciences,
U.S. Monsanto and
U.S. - Swedish Pharmacia & Upjohn, yesterday announced that they plan to merge, creating a new pharmaceutical company with a
market capitalization of over $ 50 billion.
Represented a variety of
life science and health care companies, as well as individual employees, officers, consultants and medical professionals, in criminal and civil litigation by multiple
U.S. Attorneys Offices, DOJ, HHS - OIG, qui tam Relators, state attorneys general and national Medicaid fraud control units, regarding alleged «off - label» promotion, unlawful inducements and other sales,
marketing, pricing and development activities.
BioMed Realty Trust is based in San Diego, one of the fastest - growing
markets for biotech and
life sciences in the
U.S..
BioMed «owns an exceptional collection of office buildings catering to
life -
science tenants in gateway
markets including Boston - Cambridge, San Francisco, San Diego and Seattle,» Nadeem Meghji, co-head of
U.S. real estate acquisitions for Blackstone, said in the statement.